The FDA has approved Rapiblyk, a new drug to treat irregular heartbeats in critically ill hospitalized patients with severe ...

The approval was based on data from 5 randomized, double-blind, placebo-controlled trials that included 317 patients with supraventricular tachycardia.

VIENNA--AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug ...

U.S. FDA Approves AOP Health’s Rapiblyk™ (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting ...

The following is a summary of “Role of Troponin Testing in Patients with Supraventricular Tachycardia, Systematic Review and ...

Specific patient groups in which using one of these devices to monitor for arrhythmias could be useful include those with ...

A MUM-of-two died after suffering cold, clammy hands which medics mistook and treated as something non-life-threatening.

A mum was misdiagnosed and given the wrong medication before her death, an inquest heard. Neglect contributed to the death of ...

Background: Paroxysmal supraventricular tachycardia (PSVT) is one of the most common arrhythmias among pregnant women, in part due to the maternal physiological changes that occur during pregnancy.

[15] Supraventricular arrhythmias may occur in the pre- and post-MI setting. Causes of SVT include: irritation of atrial myocardium as a result of pericarditis; elevated atrial pressures resulting ...